OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils
Kathleen M. Buchheit, Dominick Shaw, Geoffrey Chupp, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2662-2679
Open Access | Times Cited: 6
Kathleen M. Buchheit, Dominick Shaw, Geoffrey Chupp, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2662-2679
Open Access | Times Cited: 6
Showing 6 citing articles:
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
Philippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Philippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Personalized Medicine in Chronic Rhinosinusitis: Treatable Traits Using Biologics for Unmet Needs
Mitsuhiro Okano, Marie Yamada, Aiko Oka
Allergy Asthma and Immunology Research (2025) Vol. 17, Iss. 1, pp. 8-8
Open Access
Mitsuhiro Okano, Marie Yamada, Aiko Oka
Allergy Asthma and Immunology Research (2025) Vol. 17, Iss. 1, pp. 8-8
Open Access
Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma
Annina Lyly, Johanna Sahlman, Karoliina Pajala, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Annina Lyly, Johanna Sahlman, Karoliina Pajala, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies
Mayu Shiomi, Ryu Watanabe, Ryuhei Ishihara, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 544-544
Open Access
Mayu Shiomi, Ryu Watanabe, Ryuhei Ishihara, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 544-544
Open Access
Correspondence to ‘Interleukin‐5 as a Pleiotropic Cytokine Orchestrating Airway Type 2 Inflammation: Effects on and Beyond Eosinophils’
Christopher McCrae, Maria Jison, Andrew Menzies‐Gow
Allergy (2025)
Open Access
Christopher McCrae, Maria Jison, Andrew Menzies‐Gow
Allergy (2025)
Open Access
Bifunctional chemokine-nanobody fusion protein enhances neutrophil recruitment to impede Acanthamoeba immune evasion
Zhenyu Wei, Jianlong Yuan, Q Chen, et al.
EBioMedicine (2025) Vol. 115, pp. 105685-105685
Closed Access
Zhenyu Wei, Jianlong Yuan, Q Chen, et al.
EBioMedicine (2025) Vol. 115, pp. 105685-105685
Closed Access
